Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Prostate Cancer

  Free Subscription


19.05.2025

1 Am J Clin Oncol
1 BJU Int
1 Clin Cancer Res
1 Eur Radiol
1 Eur Urol
1 Genes Chromosomes Cancer
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Urol
1 Nat Rev Urol
2 PLoS One
3 Prostate
2 Radiol Imaging Cancer
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. SABBAH A, Delouya G, Laskine M, Taussky D, et al
    Metabolic Plasticity in Prostate Cancer: The Warburg Effect and Its Clinical Relevance.
    Am J Clin Oncol. 2025 May 15. doi: 10.1097/COC.0000000000001215.
    PubMed         Abstract available


    BJU Int

  2. ALSHAK MN, Higgins MI, Grutman AJ, Campbell J, et al
    Prostate cancer active surveillance in solid organ transplant: a matched study and literature review.
    BJU Int. 2025 May 14. doi: 10.1111/bju.16777.
    PubMed         Abstract available


    Clin Cancer Res

  3. DEV H, Linch M, Narahari K, Milne-Clark T, et al
    Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib +/- Degarelix in Primary Prostate Cancer.
    Clin Cancer Res. 2025 May 13:OF1-OF11. doi: 10.1158/1078-0432.CCR-24-1304.
    PubMed         Abstract available


    Eur Radiol

  4. LEE KL, Caglic I, Liao PH, Kessler DA, et al
    PI-QUAL version 2 image quality categorisation and inter-reader agreement compared to version 1.
    Eur Radiol. 2025;35:3096-3104.
    PubMed         Abstract available


    Eur Urol

  5. CHEN DC, Al-Khanaty A, Hennes D, Perera ML, et al
    Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF): A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 Trial.
    Eur Urol. 2025 May 9:S0302-2838(25)00262-3. doi: 10.1016/j.eururo.2025.
    PubMed        


    Genes Chromosomes Cancer

  6. ENIKEEVA K, Korobeynikov V, Sharifyanova Y, Akramova E, et al
    Single-Cell Profiling of Mononuclear Cells Identifies Transcriptomics Signatures Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
    Genes Chromosomes Cancer. 2025;64:e70051.
    PubMed         Abstract available


    J Clin Oncol

  7. HASSANZADEH C, Kuban D, Pasyar S, Bassett R, et al
    Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.
    J Clin Oncol. 2025 May 14:JCO2402057. doi: 10.1200/JCO-24-02057.
    PubMed         Abstract available


    J Natl Cancer Inst

  8. PATRICK SM, Ombuki WM, Ndambuki J, Oyaro MO, et al
    Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade.
    J Natl Cancer Inst. 2025 May 9:djaf117. doi: 10.1093.
    PubMed         Abstract available


    J Urol

  9. DOMINGO MR, Do DD, Conlin CC, Bagrodia A, et al
    Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with reliable positive predictive value.
    J Urol. 2025 May 16:101097JU0000000000004611. doi: 10.1097/JU.0000000000004611.
    PubMed         Abstract available


    Nat Rev Urol

  10. ADZAVON YM, Culig Z, Sun Z
    Interactions between androgen and IGF1 axes in prostate tumorigenesis.
    Nat Rev Urol. 2025;22:268-275.
    PubMed         Abstract available


    PLoS One

  11. KHOSROWZADEH N, Saini AS, Samimi K, Chambers K, et al
    Disparities in physician compensation for breast and prostate cancer operations.
    PLoS One. 2025;20:e0323892.
    PubMed         Abstract available

  12. ZHOU H, Xie M, Shi H, Shou C, et al
    Integrating multimodal imaging and peritumoral features for enhanced prostate cancer diagnosis: A machine learning approach.
    PLoS One. 2025;20:e0323752.
    PubMed         Abstract available


    Prostate

  13. MIURA Y, Yoneyama T, Yamamoto H, Suzuki H, et al
    Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population.
    Prostate. 2025;85:869-887.
    PubMed         Abstract available

  14. XUE C, Ko HK, Shi K, Pittsenbarger J, et al
    Understanding Enzalutamide-Resistance Based on a Functional Single-Cell Approach.
    Prostate. 2025;85:888-899.
    PubMed         Abstract available

  15. AGUILERA M, Klinkebiel DL, Williams V, Rovatti J, et al
    Altered Ten Eleven Translocation Methylcytosine Dioxygenase Expression and DNA Hydroxymethylation in a Mouse Model of Prostate Cancer.
    Prostate. 2025 May 11. doi: 10.1002/pros.24912.
    PubMed         Abstract available


    Radiol Imaging Cancer

  16. ALMALKI YE, Basha MAA, Ali SA, Donkol RH, et al
    Comparison of Prostate-specific Membrane Antigen Reporting and Data System Version 1.0 versus 2.0 for Prostate Cancer Assessment.
    Radiol Imaging Cancer. 2025;7:e240390.
    PubMed         Abstract available

  17. LANFRANCHI F, Belgioia L, Albano D, Triggiani L, et al
    Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study.
    Radiol Imaging Cancer. 2025;7:e240150.
    PubMed         Abstract available


    Urology

  18. FANG A, Frigo DE, Hahn A, Razouki Z, et al
    GLP-1 Agonist Use Among Men with Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials.
    Urology. 2025 May 8:S0090-4295(25)00426-1. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.